
|Articles|December 10, 2015
Special Section Media, Communications & Social Media
Author(s)DIA
Advertisement
From enhancing the clinical trial recruitment process to providing a powerful tool for communicating drug safety, mobile technology and social media are quickly becoming part of the biopharmaceutical landscape. This Special Section of the December 2015 Global Forum explores the intersection of digital technology with the patient experience, and showcases forward-thinking applications of technology into the drug development process.
To read this article,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
3
Marty Makary Out as FDA Commissioner: Report
4
Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu
5




